Allurion to Participate in Two Upcoming Investor Conferences in June 2024
-
Jefferies Global Healthcare Conference -
Sidoti Small Cap Virtual Conference
About
Allurion’s Chief Executive Officer,
The fireside chat is scheduled for
About
Allurion’s Chief Executive Officer,
The presentation is scheduled for
About Allurion
Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less intragastric balloon for weight loss, and offers access to the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Coach Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in
For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com .
Allurion is a trademark of
View source version on businesswire.com: https://www.businesswire.com/news/home/20240529694987/en/
Global Media:
PR Manager
+33 7 84 21 02 20
cdamour@allurion.com
Investors:
ICR Westwicke
(617) 877-9641
mike.cavanaugh@westwicke.com
Source: